Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052205 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Adam R Peterson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Regenerative Medicine, Cell- and Tissue-Based Therapy. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Regenerative medicine, and in particular cell-based therapies, are under investigation as therapeutics in the management of inflammatory bowel disease, where despite significant advancements in management, prolonged remission is achieved in less than half of patients experiencing these disorders. In contrast to conventional immunomodulatory medications, these therapies are hypothesised to act through multiple pathways including via regenerative mechanisms, which may enable them to break through the current therapeutic ceiling. Potential therapy candidates include mesenchymal stem cells, human amnion epithelial cells, and regulatory T-cells, as well as their derivatives including extracellular vesicles. Extensive preclinical studies have demonstrated the multi-modal nature of these therapies as well as shared and unique properties. Controversy remains regarding contradictory study outcomes and the efficacy of regenerative therapies in human trials. In this narrative review, we first examine the mechanisms of these candidate cell therapies, including signalling via cytokines and extracellular vesicles, and interactions with immune cells, stromal cells, and the microbiome to determine differences and similarities between them. The second part delves into the current state of regenerative and cell-based therapy, focusing on mesenchymal stem cell, human amnion epithelial cell, T regulatory cells, and their respective extracellular vesicles in IBD treatment. Finally, we close by identifying the major literature gaps and barriers to bringing regenerative medicines to clinical use, resulting in recommendations for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
- Gastroenterology Department, Monash Health, Clayton, VIC 3168, Australia.
- The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.
ORCID-Profile: Adam R Peterson, Peter J Eggenhuizen, Joshua Ooi, Gregory T Moore, Rimma Goldberg
Zitieren
APA
Peterson, A. R., Eggenhuizen, P. J., Gan, P. Y., Keung, C., Ooi, J., Moore, G. T., & Goldberg, R. (2026). Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052205
Vancouver
Peterson AR, Eggenhuizen PJ, Gan PY, Keung C, Ooi J, Moore GT, et al. Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052205
BibTeX
@article{Peterson2026,
author = {Peterson, Adam R and Eggenhuizen, Peter J and Gan, Poh-Yi and Keung, Charlotte and Ooi, Joshua and Moore, Gregory T and Goldberg, Rimma},
title = {Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052205}
}
EUVIMED